Jim Simons Benitec Biopharma Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.18 - $0.36 $27,117 - $54,234	-150,652 Reduced 40.12%	224,879 $47,000
Q4 2022 Feb 13, 2023	BUY	$0.13 - $5.95 $33,163 - $1.52 Million	255,102 Added 211.83%	375,531 $64,000
Q3 2022 Nov 14, 2022	BUY	$0.31 - $6.32 $37,332 - $761,111	120,429 New	120,429 $45,000
Q3 2021 Nov 12, 2021	SELL	$3.49 - $4.26 $149,023 - $181,902	-42,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.94 - $5.81 $168,238 - $248,086	42,700 New	42,700 $181,000
Q1 2021 May 13, 2021	SELL	$2.59 - $9.26 $131,209 - $469,111	-50,660 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.61 - $4.79 $132,222 - $242,661	50,660 New	50,660 $152,000

1.42M

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $280M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.